since initial announcement mid august lot buzz treatment mike wilson posted following translation kd downunder facebook page comments posted others living kd interesting article referring found takeda co jp news trial first introduced back i posted article read month i posted announcement long term trial results found interesting news new treatment sbma approved japan leuplin sr injection kit mg japan supplemental approval indication suppression progression spinal bulbar muscular atrophy pleased announce spinal bulbar muscular spinal bulbar muscular disease ministry health labor welfare leuprin sr injection kit mg generic name leuprorelin acetate pleased announce received additional indication suppression progression atrophy sbma leuplin sr week sustained release sustained release preparation highly active lh rh agonist luteinizing hormone releasing hormone derivative synthesized sumitomo chemical acts continuously pituitary gland inhibits production sex hormones reducing reactivity drug used therapeutic agent hormone dependent diseases prostate cancer premenopausal breast cancer japan acquisition additional indication indication mainly evaluated based results doctor initiated trials examined effectiveness safety leuplin sr patients sbma centering nagoya university neurology department world first approval therapeutic agent progression sbma toshiro taniya director company japan development center said date effective treatment sbma established domestically internationally drugs could contribute treatment disease sought become world first medicine useful treating patients sbma appreciate patients doctors cooperated developing drug patient medical staff strive deliver medicines diseases high unmet medical needs indications effects dosage dosage approved time indications effects inhibition progression spinal bulbar muscular atrophy dosage administration usually adults receive mg subcutaneously leuprorelin acetate every weeks upon administration push plunger rod injection needle facing upward move whole amount suspension liquid powder part carefully suspend use taking care foam sbma sbma characterized muscle atrophy linked lower motor neuron disease develops adult male due abnormal accumulation mutant androgen receptor polyglutamine nucleus androgen hormone dependent neuronal damage occurs usually develops around years old follows slow progressive course forced live bed chair bedridden life end year also repeats aspiration pneumonia japan stipulated designated intractable disease reported number persons specific medical care recipient passengers research specific diseases ministry health labor welfare fy